Food/Recall·openFDA/food

El Ruisenor De Mexico, Inc. — Class II: Fritura mixed dry fruit; packed in a clear plastic 1lb, 5lb, 25lb unit sizes. no UPC

MediumPublished Oct 28, 2026· AI-analyzed Nov 2, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

El Ruisenor De Mexico, Inc. has initiated a Class II recall for its 'Fritura mixed dry fruit' products due to undeclared allergens and additives, specifically Wheat, Yellow #5, and Yellow #6. The affected products were distributed in clear plastic units of 1lb, 5lb, and 25lb sizes without UPC codes.

Who it affects

This recall affects food manufacturers, distributors, and packaging facilities involved in the processing of mixed dry fruit products, particularly those utilizing clear plastic bulk packaging without standardized UPC identification.

Why it matters

The presence of undeclared wheat and specific color additives represents a significant regulatory non-compliance that necessitates a Class II recall due to potential health risks for sensitive populations. The lack of a UPC on the packaging may complicate the tracking and removal of affected units from the supply chain, potentially increasing the complexity of the ongoing recall process.

Practical takeaway

Regulatory and QA teams should review allergen management protocols and labeling verification procedures to ensure that all ingredients, including color additives like Yellow #5 and #6, are accurately declared on final packaging. Verification of bulk-to-unit packaging workflows is advised to prevent omissions in ingredient statements.

FDA source material

Class II. Reason: undeclared allergen ingredient (Wheat, Yellow #5, Yellow #6). Product: Fritura mixed dry fruit; packed in a clear plastic 1lb, 5lb, 25lb unit sizes. no UPC. Firm: El Ruisenor De Mexico, Inc. (Vernon CA United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.